At a glance
- Originator Nissin Food Products
- Class Anti-inflammatories; Glucocorticoids
- Mechanism of Action Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Inflammation
Most Recent Events
- 29 Jan 1999 New profile
- 29 Jan 1999 Preclinical development for Inflammation in Japan (Unknown route)